323 filings
Page 9 of 17
4
RVLPQ
RVL Pharmaceuticals plc
20 May 21
Osmotica Pharmaceuticals / Andrew J. Einhorn ownership change
4:06pm
4
RVLPQ
RVL Pharmaceuticals plc
20 May 21
Osmotica Pharmaceuticals / Tina Marie deVries ownership change
4:05pm
DEFA14A
RVLPQ
RVL Pharmaceuticals plc
19 May 21
Additional proxy soliciting materials
4:05pm
10-Q
2021 Q1
RVLPQ
RVL Pharmaceuticals plc
Quarterly report
13 May 21
5:01pm
8-K
RVLPQ
RVL Pharmaceuticals plc
13 May 21
Osmotica Pharmaceuticals plc Reports First Quarter 2021 Results and Provides Business Update
4:19pm
SC 13G/A
Orbit Co-Invest I LLC
29 Apr 21
Osmotica Pharmaceuticals / Orbit Co-Invest I ownership change
4:49pm
DEFA14A
RVLPQ
RVL Pharmaceuticals plc
28 Apr 21
Additional proxy soliciting materials
5:14pm
DEF 14A
RVLPQ
RVL Pharmaceuticals plc
Definitive proxy
26 Apr 21
4:05pm
PRE 14A
RVLPQ
RVL Pharmaceuticals plc
Preliminary proxy
9 Apr 21
5:00pm
10-K
2020 FY
RVLPQ
RVL Pharmaceuticals plc
Annual report
30 Mar 21
5:01pm
8-K
RVLPQ
RVL Pharmaceuticals plc
30 Mar 21
Osmotica Pharmaceuticals plc Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
12:00am
8-K
RVLPQ
RVL Pharmaceuticals plc
9 Mar 21
Corporate Presentation Barclays Global Healthcare Conference March 2021
10:30am
4
Schaub James
26 Jan 21
Osmotica Pharmaceuticals / James Schaub ownership change
7:03pm
4
Klein Christopher
26 Jan 21
Osmotica Pharmaceuticals / Christopher Klein ownership change
7:03pm
4
RVLPQ
RVL Pharmaceuticals plc
26 Jan 21
Osmotica Pharmaceuticals / Andrew J. Einhorn ownership change
7:02pm
4
RVLPQ
RVL Pharmaceuticals plc
26 Jan 21
Osmotica Pharmaceuticals / Tina Marie deVries ownership change
7:01pm
4
RVLPQ
RVL Pharmaceuticals plc
26 Jan 21
Osmotica Pharmaceuticals / FRED G WEISS ownership change
7:01pm
4
Cowan Gregory L
26 Jan 21
Osmotica Pharmaceuticals / GREGORY L COWAN ownership change
7:00pm
8-K
RVLPQ
RVL Pharmaceuticals plc
25 Jan 21
Other Events
9:00am
8-K
RVLPQ
RVL Pharmaceuticals plc
29 Dec 20
Osmotica Pharmaceuticals plc Receives Complete Response Letter from U.S. Food and Drug Administration for Arbaclofen Extended Release Tablets
5:21pm